Repository logo
 

Solvent exposure of Tyr10 as a probe of structural differences between monomeric and aggregated forms of the amyloid-β peptide.


Change log

Authors

Aran Terol, Pablo 
Kumita, Janet R 
Hook, Sharon C 
Dobson, Christopher M 
Esbjörner, Elin K 

Abstract

Aggregation of amyloid-β (Aβ) peptides is a characteristic pathological feature of Alzheimer's disease. We have exploited the relationship between solvent exposure and intrinsic fluorescence of a single tyrosine residue, Tyr10, in the Aβ sequence to probe structural features of the monomeric, oligomeric and fibrillar forms of the 42-residue Aβ1-42. By monitoring the quenching of Tyr10 fluorescence upon addition of water-soluble acrylamide, we show that in Aβ1-42 oligomers this residue is solvent-exposed to a similar extent to that found in the unfolded monomer. By contrast, Tyr10 is significantly shielded from acrylamide quenching in Aβ1-42 fibrils, consistent with its proximity to the fibrillar cross-β core. Furthermore, circular dichroism measurements reveal that Aβ1-42 oligomers have a considerably lower β-sheet content than the Aβ1-42 fibrils, indicative of a less ordered molecular arrangement in the former. Taken together these findings suggest significant differences in the structural assembly of oligomers and fibrils that are consistent with differences in their biological effects.

Description

Keywords

Acrylamide quenching, Amyloid fibril, Amyloid-β, Aβ oligomer, tyrosine fluorescence, Amino Acid Sequence, Amyloid beta-Peptides, Dimerization, Molecular Probe Techniques, Molecular Sequence Data, Multiprotein Complexes, Peptide Fragments, Protein Conformation, Solvents, Structure-Activity Relationship, Tyrosine

Journal Title

Biochem Biophys Res Commun

Conference Name

Journal ISSN

0006-291X
1090-2104

Volume Title

468

Publisher

Elsevier BV
Sponsorship
This work was funded by grants to E.K.E from the Wenner-Gren Foundations, the Hasselblad Foundation, and the Swedish Innovation Agency (Vinnova) and to C.M.D from the Wellcome Trust. The TEM imaging was carried out in the Multi-Imaging Unit in the Department of Physiology, Development and Neuroscience, University of Cambridge, UK and quantitative amino acid analysis was carried out at the Protein and Nucleic Acid Chemistry Facility, Department of Biochemistry, University of Cambridge, UK.